Treatment of adipocyte-secreted angiotensin II enhanced the expression of ACSS2 in myeloma cells, which promotes tumorigenesis by maintaining the stability of interferon regulatory factor 4 (IRF4), an oncogenic protein (Li et al. 2021). Here, IRF4 is linked to plasma cell myeloma.